ArticleEcancermedicalscience2021

Phase 2 non-randomised trial of secondary cytoreduction and hyperthermic intraperitoneal chemotherapy in recurrent platinum-sensitive ovarian cancer.

Hemanth Raj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.